Total Voting Rights

RNS Number : 6126Y

Avacta Group PLC

10 September 2015

 



10 September 2015

Avacta Group plc

("Avacta", the "Company" or the "Group")

Total Voting Rights

The Company would like to confirm that Avacta's issued share capital consists of 6,740,649,550 Ordinary Shares of 0.1p each with voting rights, and not 6,740,149,550 as was incorrectly stated in the Company's announcement on 3 September 2015.

The above figure of 6,740,649,550 should be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FSA's Disclosure and Transparency Rules. The Company does not hold any shares in Treasury.

- Ends -

For further information:

Avacta Group plc Tim Sykes, Chief Financial Officer	Tel:  [phone] www.avacta.com
Numis Securities Limited     Michael Meade / Freddie Barnfield - Nominated Adviser James Black - Corporate Broking	Tel:  [phone] www.numiscorp.com
Media Enquiries FTI Consulting Simon Conway/Natalie Garland-Collins	Tel: [phone] [e-mail]

About Avacta Group plc - www.avacta.com

Avacta Group plc is a global provider of innovative technologies, consumables and reagents for the life science markets, from drug discovery to diagnostics. Avacta operates through two divisions:

Avacta Animal Health www.avactaanimalhealth.com	Veterinary diagnostics reference laboratory and diagnostic kit provider.
Avacta Life Sciences www.avactalifesciences.com	Novel non-antibody affinity reagents called Affimers, with a wide range of Life Science applications in diagnostics, drug and biomarker discover and biotech research and development.

 

END

 

 

TVRLKLLBEKFLBBV